Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Biogazelle is a genomics and transcriptomics service provider for research, clinical trials, diagnostics, and therapeutic development. Its key focus areas include liquid biopsy, non-coding RNA, and RNA biomarker discovery, development, and validation. It is worth noting that, based on the scraped text, its core offering is not typical SaaS software, but rather laboratory testing, bioinformatics analysis, and customized project services.
Its services cover RNA sequencing, qPCR/RT-qPCR, digital PCR, gene expression analysis, copy number analysis, SNP genotyping, fusion gene detection, ASO screening, custom primer design, and sample preparation. Biogazelle can process many sample types, including FFPE, whole blood, PBMCs, plasma, serum, urine, CSF, and cells, and supports species such as humans, mice, and rats. The text also mentions an integrated workflow covering RNA extraction, library preparation, sequencing, data analysis, and reporting, as well as data processing software such as qbase+ and Cobra.
The website does not disclose plans, pricing, trials, or free-tier information. Pricing is likely based mainly on project-based consulting and laboratory service quotes. Compliance is a notable strength: services are performed in ISO17025-accredited and GCLP-compliant laboratory environments, making it suitable for customers with requirements around clinical trial samples, quality systems, and traceability.
Its strengths lie in its technical depth, especially in RNA, non-coding RNA, liquid biopsy, qPCR/dPCR, and clinical sample handling, all of which are described in detail. It can also provide custom primer design and experimental validation. The drawbacks are the lack of SaaS-style features such as an online workspace, permission management, APIs, third-party business system integrations, transparent pricing, and delivery SLA information. Buyers will need to confirm details through the contact form before procurement.
Biogazelle is better suited to pharmaceutical companies, diagnostics companies, clinical research teams, and university/hospital research groups for biomarker discovery, clinical trial sample analysis, fusion gene detection, and ASO drug development. Access and payment options from mainland China are not specified, so they should be considered unknown. For local alternatives, users may evaluate sequencing and molecular testing service providers such as BGI, Novogene, and GenScript.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on biogazelle.com official site.
biogazelle.com is an Belgium SaaS provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach biogazelle.com directly.